Eko has received FDA clearance for two artificial intelligence algorithms embedded into the healthcare technology company's digital stethoscope to detect serious heart conditions, the company ...
Heart disease remains the leading cause of death in the U.S. and around the world, but rapid, early screening options are still few and far between. Digital stethoscope developer Eko hopes to change ...
Berkeley, California-based Eko Devices has received FDA clearance for Duo, a smart heart monitor that is a combination of a digital stethoscope and portable electrocardiogram. Duo is intended as a ...
Eko’s smart stethoscopes have been used by U.S. physicians to automatically detect signs of atrial fibrillation and heart murmurs since its first FDA clearance arrived in 2020. A new regulatory OK ...
Cardiovascular and pulmonary diseases are among the leading causes of death worldwide, with millions of patients unaware of their risk factors, often due to limited access to effective detection tools ...
Landmark TRICORDER study finds major gains in detection of heart failure, atrial fibrillation, and valvular disease with Eko Health's AI-enabled stethoscopes in routine exams. SAN FRANCISCO, Sept. 11, ...
The first-of-its-kind offering builds upon that promise, pairing Eko’s groundbreaking FDA-cleared CORE 500™ Digital Stethoscope with FIGS’ commitment to design, comfort, and functionality, while ...
HOBOKEN, N.J. and OAKLAND, Calif., July 14, 2021 /PRNewswire/ -- Health Recovery Solutions, a leading provider of telehealth and remote patient monitoring solutions, today announced a partnership with ...
The CORE 500™ Digital Stethoscope is Eko's most advanced stethoscope to date, designed to enhance clinical assessments through patented audio technology with three listening modes (cardiac, pulmonary, ...
After receiving FDA clearance to use its digital stethoscope to detect heart rhythm abnormalities, startup Eko plans to build a suite of telehealth tools around its connected devices. The Berkeley, ...
SANTA MONICA, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, and Eko Health, Inc. (“Eko”), a leading innovator in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results